Sotera Health (SHC)
Sotera Health Statistics
Share Statistics
Sotera Health has 283.47M shares outstanding. The number of shares has increased by 0.14% in one year.
| Shares Outstanding | 283.47M |
| Shares Change (YoY) | 0.14% |
| Shares Change (QoQ) | 0.08% |
| Owned by Institutions (%) | 93.25% |
| Shares Floating | 152.4M |
| Failed to Deliver (FTD) Shares | 1.95K |
| FTD / Avg. Volume | 0.17% |
Short Selling Information
The latest short interest is 6.9M, so 2.44% of the outstanding shares have been sold short.
| Short Interest | 6.9M |
| Short % of Shares Out | 2.44% |
| Short % of Float | 4.52% |
| Short Ratio (days to cover) | 6.62 |
Valuation Ratios
The PE ratio is 87.13 and the forward PE ratio is 17.46. Sotera Health's PEG ratio is -7.84.
| PE Ratio | 87.13 |
| Forward PE | 17.46 |
| PS Ratio | 3.52 |
| Forward PS | 2.4 |
| PB Ratio | 9.55 |
| P/FCF Ratio | 85.79 |
| PEG Ratio | -7.84 |
Enterprise Valuation
Sotera Health has an Enterprise Value (EV) of 5.94B.
| EV / Sales | 5.4 |
| EV / EBITDA | 13.44 |
| EV / EBIT | 26.51 |
| EV / FCF | 131.77 |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 5.81.
| Current Ratio | 2.75 |
| Quick Ratio | 2.5 |
| Debt / Equity | 5.81 |
| Debt / EBITDA | 5.32 |
| Debt / FCF | 52.13 |
| Interest Coverage | 1.81 |
Financial Efficiency
Return on Equity is 10.96% and Return on Invested Capital is 4%.
| Return on Equity | 10.96% |
| Return on Assets | 1.45% |
| Return on Invested Capital | 4% |
| Revenue Per Employee | $366.81K |
| Profits Per Employee | $14.8K |
| Employee Count | 3,000 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 10.13 |
Taxes
| Income Tax | 69.48M |
| Effective Tax Rate | 61.01% |
Stock Price Statistics
The stock price has increased by -0.43% in the last 52 weeks. The beta is 1.93, so Sotera Health's price volatility has been higher than the market average.
| Beta | 1.93 |
| 52-Week Price Change | -0.43% |
| 50-Day Moving Average | 12.73 |
| 200-Day Moving Average | 13.87 |
| Relative Strength Index (RSI) | 41.38 |
| Average Volume (20 Days) | 1.13M |
Income Statement
In the last 12 months, Sotera Health had revenue of 1.1B and earned 44.4M in profits. Earnings per share was 0.16.
| Revenue | 1.1B |
| Gross Profit | 602.29M |
| Operating Income | 297.63M |
| Net Income | 44.4M |
| EBITDA | 442.2M |
| EBIT | 278.56M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 277.24M in cash and 2.35B in debt, giving a net cash position of -2.07B.
| Cash & Cash Equivalents | 277.24M |
| Total Debt | 2.35B |
| Net Cash | -2.07B |
| Retained Earnings | -610.04M |
| Total Assets | 3.07B |
| Working Capital | 335.04M |
Cash Flow
In the last 12 months, operating cash flow was 224.16M and capital expenditures -179.07M, giving a free cash flow of 45.09M.
| Operating Cash Flow | 224.16M |
| Capital Expenditures | -179.07M |
| Free Cash Flow | 45.09M |
| FCF Per Share | 0.16 |
Margins
Gross margin is 54.73%, with operating and profit margins of 27.05% and 4.03%.
| Gross Margin | 54.73% |
| Operating Margin | 27.05% |
| Pretax Margin | 10.35% |
| Profit Margin | 4.03% |
| EBITDA Margin | 40.18% |
| EBIT Margin | 27.05% |
| FCF Margin | 4.1% |
Dividends & Yields
SHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.15% |
| FCF Yield | 1.17% |
Analyst Forecast
The average price target for SHC is $16.5, which is 43.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.5 |
| Price Target Difference | 43.6% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 1.49 |
| Piotroski F-Score | 8 |